Key Note 1: Mold infection in patients with severe influenza or COVID-19: Aspects on epidemiology and diagnostics.

Is invasive pulmonary aspergillosis (IPA) in patients with severe viral respiratory infections, such as influenza and covid-19, primarily a problem in the Netherlands and Belgium? Or is it an underdiagnosed complication in the rest of the world? In this key-note seminar, Professor Paul Verweij, Radboud University, Netherlands, will present epidemiological and clinical data regarding IPA as a complication to influenza and covid-19 and compare with the presentation in immunocompromised patients. Professor Cornelia Lass-Flörl, Medical Universty of Innbruck, Austria, will give an overview of available microbiological diagnostic methods with special consideration to their performance in patients with severe viral respiratory infections. 

Moderator: Ola Blennow och Volkan Özenci

Mold infection in patients with severe influenza or Covid-19: Epidemiology and clinical characteristics
Professor Paul E. Verweij, Radboudumc – CWZ Center of Expertise for Mycology, Radboud University Nijmegen Medical Center;
Center for Infectious Disease Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment, Netherlands

Mold infection in patients with severe influenza or Covid-19: Epidemiology and clinical characteristics
Professor Cornelia Lass-Flörl, Director, Institute of Hygiene and Medical Microbiology Director, CD-Laboratory for Invasive Fungal Infections European Excellence Center of Medical Mycology (ECMM), Medical University of Innsbruck, Austria

 Lokal: Erling Persson Aula


Följ oss: #INFEKTIONMIKRO

logo    logo


© Infektionsveckan / Mikrobiologiskt vårmöte 2022